Cargando…
Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
Autores principales: | Verma, Megha, Beaulieu-Abdelahad, David, Ait-Ghezala, Ghania, Li, Rena, Crawford, Fiona, Mullan, Michael, Paris, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521847/ https://www.ncbi.nlm.nih.gov/pubmed/26230317 http://dx.doi.org/10.1371/journal.pone.0134776 |
Ejemplares similares
-
Chronic Anatabine Treatment Reduces Alzheimer’s Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD
por: Verma, Megha, et al.
Publicado: (2015) -
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013) -
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017) -
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010) -
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism
por: Paris, Daniel, et al.
Publicado: (2011)